Tradestie Institutional Equity Comparison Engine
PMI vs SGHT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PMI Overall Edge
PMI Captures Institutional Edge (3โ1 Pillars ยท 5โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Picard Medical, Inc. (PMI) driven by superior Valuation, Growth & Margin, Momentum & Technical while SGHT counters with relative strength in Options & Structure. Fundamentally, PMI trades at N/M Forward P/E with -248.1% operating margin (+38.6% YoY revenue) versus SGHT at N/M Forward P/E and -20.2% operating margin (+25.2% YoY). In options structure, PMI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SGHT sits in BREAKOUT (8th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
PMI
PMI N/M vs SGHT N/M Fwd P/E
Growth & Margin Winner
PMI
Op Margin -248.1% vs -20.2% ยท YoY +38.6% vs +25.2%
Momentum & Technical Winner
PMI
1Y +107.2% vs +48.7% ยท 52W Pos 34% vs 88%
Options & Structure Winner
SGHT
UNCLASSIFIED (N/A IV) vs BREAKOUT (8th %ile IV)
PMI
NYSE American
Picard Medical, Inc.
Surgical & Medical Instruments & Apparatus
$6.30
-2.17% 1D
Market Cap
$17.1M
1M Return
-34.58%
1Y Return
+107.24%
Forward P/E
N/M
Unified AI Score
48.4 / 100
HOLD
Tech 39.0
Fund 45.0
Flow 50.0
Mom 50.0
SGHT
NASDAQ
Sight Sciences, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$10.62
-1.39% 1D
Market Cap
$598.6M
1M Return
+22.07%
1Y Return
+48.74%
Forward P/E
N/M
Unified AI Score
34.0 / 100
SELL
Tech 50.0
Fund 39.0
Flow 70.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
PMI +107.24%
SGHT +48.74%
Spread: +99.29 pp (PMI Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | PMI Revenue | SGHT Revenue | PMI Op. Margin | SGHT Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2020 | N/A | $30M | N/A | -116.5% | SGHT |
| FY2021 | N/A | $50M | N/A | -105.2% | SGHT |
| FY2022 | N/A | $70M | N/A | -117.7% | SGHT |
| FY2023 | N/A | $80M | N/A | -70.7% | SGHT |
| FY2024 | $0M | $80M | -312.3% | -63.3% | SGHT |
| FY2025 | $0M | $80M | -268.4% | -48.0% | SGHT |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PMI | SGHT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $17.1M | $598.6M | Larger Scale | SGHT |
| Trailing P/E Ratio Valuation | 2.9x | N/M | Lower Multiple | PMI |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +38.6% | +25.2% | Higher Growth | PMI |
| Operating Margin (TTM) Profitability | -248.1% | -20.2% | Higher Margin | SGHT |
| Net Profit Margin Profitability | 0.0% | -32.1% | Higher Margin | PMI |
| Return on Equity (ROE) Capital Efficiency | 0.0% | -50.1% | Higher ROE | PMI |
| 52-Week Range Position Momentum | 34% ($0โ$18) | 88% ($3โ$12) | Stronger Trend | SGHT |
| Beta / 30D Volatility Risk Regime | 54.06ฮฒ ยท 134% Vol | 1.06ฮฒ ยท 46% Vol | Lower Realized Risk | SGHT |
| Unified Institutional Score Composite Signal | 48.4 / 100 (HOLD) | 34.0 / 100 (SELL) | Higher Composite | PMI |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full PMI vs SGHT Buy Guide
PMI
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
SGHT
BREAKOUT
36d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
8th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither PMI nor SGHT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.